agilon health(US:AGL) TMX Newsfile·2026-02-21 13:11Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to allegations of violations of federal securities laws, particularly regarding misleading statements and guidance related to the company's financial performance [2][4]. Group 1: Legal Investigation and Claims - The firm is encouraging investors who suffered losses in agilon health between February 26, 2025, and August 4, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against agilon health, with a deadline of March 2, 2026, for investors to seek the role of lead plaintiff [2]. - The complaint alleges that agilon health and its executives made false statements and failed to disclose significant industry challenges, leading to misleading information about the company's business and financial outlook [4]. Group 2: Financial Impact and Stock Performance - On August 4, 2025, agilon health announced the suspension of its full-year 2025 financial guidance, citing more severe industry headwinds than previously anticipated [5]. - Following this announcement, agilon health's stock experienced a significant decline of 51.5% on August 5, 2025 [5]. Group 3: Firm Background and Encouragement for Whistleblowers - Faruqi & Faruqi, LLP has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding agilon health's conduct [7].